Protagonist Therapeutics, Inc. (PTGX)

87.25 -0.68 (-0.77%) USD  |  NASDAQ  |  Dec 30, 16:00
87.25 0.00 (0.00%) After-Hours: 20:00
More

Protagonist Therapeutics Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
MannKind Corp. Upgrade